肺心病急性发作期的中医治疗思路探讨  

Treating pulmonary heart disease at acute attack stage in TCM

作　　者：程刚[1] 

机构地区：[1]江苏省昆山市中医医院,江苏昆山215300

出　　处：《中医临床研究》2017年第28期78-79,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨采用中医治疗分析肺心病急性发作期患者的思路及临床疗效。方法:选取我院2012-2015年期间收治的42例肺心病急性发作期患者,按照不同治疗方案随机分为两组,对照组采用单纯的西医治疗,治疗组在对照组基础上配合生脉散合真武汤加减治疗,对比分析两组患者治疗效果以及治疗前后动脉血氧分压(Pa O2)、动脉血二氧化碳分压(Pa CO2)等血气指标变化情况。结果:治疗组患者治疗总有效率为95.2%,显著高于对照组的76.2%(P<0.05)。两组患者治疗后Pa CO2明显低于治疗前(P<0.05),两组治疗后Pa O2显著高于治疗前(P<0.05),但治疗组患者治疗前后改善情况优于对照组(P<0.05)。结论:采用中西医结合治疗肺心病急性发作期患者的临床效果优于单纯西医治疗,可更有效改善患者临床症状,是一种值得推荐的治疗思路。Objective:To investigate clinical efficacy of TCM therapy on pulmonary heart disease at acute attack stage.Methods:42patients were divided into2groups.The control group was given western medicine;and the treatment group was given Shengmai San plus the Zhenwu decoction more.Efficiency,PaO2and PaCO2in two groups were observed.Results:The total efficiency was95.2%in the treatment group,higher than76.2%in the control group(P<0.05).After treatment,PaCO2in two groups were decreased(P<0.05).PaO2in two groups were increased(P<0.05).After treatment,the improvement in the treatment group was better(P<0.05).Conclusion:TCM therapy on pulmonary heart disease at acute attack stage shows a good effect,could improve clinical symptoms,and is worthy of promotion.

关 键 词：肺心病急性发作期 中医治疗思路 临床分析 

分 类 号：R541.5[医药卫生—心血管疾病]